Tourniquet vs. Dual-flow Arthroscopy Sheath in Anterior Cruciate Ligament (ACL) Reconstruction (RELICA)

A Prospective, Randomized Controlled Study Comparing Tourniquet Use Versus a Dual-flow Arthroscopy Sheath in Anterior Cruciate Ligament (ACL) Reconstruction Surgery.

This is a prospective randomized study comparing tourniquet use versus a dual-flow arthroscopy sheath in Anterior Cruciate Ligament (ACL) reconstruction surgery.

The ACL is largely responsible for knee stability and contributes to central pivot with the posterior cruciate ligament. ACL rupture is associated with a violent twisting motion of the knee, which is usually irreparable without surgical intervention.

ACL reconstruction via arthroscopy is the gold standard treatment for young, active patients with knee instability. Reconstruction is commonly performed using a thigh tourniquet to improve intraoperative visibility, reduce bleeding, and shorten procedure time. However, numerous studies associate tourniquet use with an increased risk of postoperative complications such as increased pain, muscle injury, postoperative bleeding, and deep vein thrombosis. Therefore, it seems relevant to conduct further investigations into the benefits of new methods to replace tourniquet. In this context, the dual-flow arthroscopy sheath could improve postoperative recovery after ACL reconstruction and could limit the risk of complications, thus improving ambulatory care for patients.

This study propose to compare two groups of patients undergoing ACL reconstruction: those operated on with a tourniquet versus those operated on using the dual-flow arthroscopy sheath.

Study Overview

Detailed Description

Initial assessments will be conducted preoperatively. The follow-up examination will take place during the first 7 days following surgery and then at 21 days (D21), 45 days (D45), and 5 months postoperatively.

Study Type

Interventional

Enrollment (Estimated)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Var
      • Hyères, Var, France, 83400
      • Toulon, Var, France, 83100
        • Recruiting
        • Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Primary ACL reconstruction
  • Age 18 years or older
  • Provided informed consent prior to study participation
  • Affiliated to or beneficiary of a social security regimen

Exclusion Criteria:

  • Multi-ligamentous surgery
  • Revision ACL surgery
  • Presence of a meniscal and/or chondral lesion not allowing immediate weight-bearing postoperatively
  • Bleeding disorder
  • Pregnant, parturient or breastfeeding women
  • Patient under legal guardianship
  • Any other reason which, in the opinion of the investigator, could interfere with the evaluation of the objectives of the study objectives

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dual-flow arthroscopy sheath
Patients will undergo ACL reconstruction using a dual-flow arthroscopy sheath.
ACL reconstruction will be performed by the surgeon without a tourniquet but using a dual-flow arthroscopy sheath.
Active Comparator: Thigh tourniquet
Patients will undergo ACL reconstruction using a thigh tourniquet.
ACL reconstruction will be performed by the surgeon using a thight tourniquet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain intensity according to a Numeric Rating Scale (NRS)
Time Frame: 4 days after surgery

Pain intensity will be assessed using a Numeric Rating Scale (NRS) at 8 AM, 12 PM, and 8 PM on postoperative day 4.

The minimum value of the scale, corresponding to no pain at all, is 0 and the maximum value is 10.

4 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity according to a Numeric Rating Scale (NRS)
Time Frame: Up to 3 days after surgery

Pain intensity will be assessed using a Numeric Rating Scale (NRS) on the day of surgery (preoperatively and at 4, 12, and 16 hours postoperatively) and on days 1, 2, and 3 following surgery (at 8 AM, 12 PM, and 8 PM).

The minimum value of the scale, corresponding to no pain at all, is 0 and the maximum value is 10.

Up to 3 days after surgery
Total antalgic consumption
Time Frame: Up to 4 days after surgery
Total antalgic consumption will be assessed in number of doses per type of drug, from surgery up to 4 days after surgery.
Up to 4 days after surgery
Arthrogenic Muscle Inhibition (AMI) classification
Time Frame: Preoperative, on Day 0 before and after surgery and then on Day 21 and Day 45 after surgery.
This classification is used to assess quadriceps contraction.
Preoperative, on Day 0 before and after surgery and then on Day 21 and Day 45 after surgery.
Lysholm knee scoring scale
Time Frame: Preoperative, Day 21, Day 45 and Month 5 after surgery
The Lysholm Knee Score is a standardized questionnaire used to assess knee function after surgery. The total score obtained ranges from 0 to 100. The higher the score, the better the knee's function.
Preoperative, Day 21, Day 45 and Month 5 after surgery
Knee Blessure and Osteoarthritis Outcomescore (KOOS)
Time Frame: Preoperative, Day 21, Day 45 and Month 5 after surgery

The KOOS is a self-administered questionnaire that evaluates multiple aspects of knee health, including pain, symptoms, daily living activities, sports and recreation function, and quality of life.

Each subscale is rated from 0 to 100, where 0 represents extreme problems and 100 represents no problem.

Preoperative, Day 21, Day 45 and Month 5 after surgery
Knee mobility
Time Frame: Preoperative, Day 21, Day 45 and Month 5 after surgery
Knee mobility will be assessed using a goniometer.
Preoperative, Day 21, Day 45 and Month 5 after surgery
Total surgical time
Time Frame: Day 0
Assessed in minutes
Day 0
Arthroscopic time
Time Frame: During procedure
Assessed in minutes
During procedure
Intraoperative visibility
Time Frame: During procedure
Intraoperative visibility will be assessed by the surgeon using a 4-point scale (excellent, good, fair, poor).
During procedure
Thigh, knee and calf diameters in cm
Time Frame: Preoperative and Day 21
Diameters will be evaluated in cm.
Preoperative and Day 21
CPK blood level
Time Frame: Preoperative and Day 1
Preoperative and Day 1
Hemoglobin level
Time Frame: Preoperative, Day 1 and Day 7
Preoperative, Day 1 and Day 7
Presence of complications
Time Frame: Up to 5 months
The number and type of complications will be recorded, including hematomas, knee stiffness, deep vein thrombosis, complex regional pain syndrome, deep infection, superficial infection, and recurrent anterior cruciate ligament graft rupture.
Up to 5 months
Muscle strength
Time Frame: Preoperative and 5 months
Muscle strength will be assessed in both limbs using isokinetic testing
Preoperative and 5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Cédric SIEDLECKI, MD, Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer and Centre Hospitalier de Hyères

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 12, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

February 5, 2025

First Submitted That Met QC Criteria

February 10, 2025

First Posted (Actual)

February 11, 2025

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 10, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-CHITS-007
  • 2024-A01117-40 (Other Identifier: ID-RCB number)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Reconstruction

Clinical Trials on ACL reconstruction with a dual-flow arthroscopy sheath

Subscribe